InvestorsHub Logo

entdoc

01/24/14 11:48 AM

#157920 RE: entdoc #157918

...and radiofrequency ablation applied to Bavi?:
Radiology. 2013 May;267(2):405-13. doi: 10.1148/radiol.13120249. Epub 2013 Feb 25 Radiofrequency ablation and immunostimulant OK-432: combination therapy enhances systemic antitumor immunity for treatment of VX2 lung tumors in rabbits.Hamamoto S, Okuma T, Yamamoto A, Kageyama K, Takeshita T, Sakai Y, Nishida N, Matsuoka T, Miki Y.
"Survival was significantly prolonged in the combination therapy group..."
"CONCLUSION: Combining RFA with local injection of immunostimulant OK-432 may lead to indirectly activation of systemic antitumor immunity."

asmarterwookie

01/24/14 12:14 PM

#157926 RE: entdoc #157918

Thanks entdoc...I didn't see it. What is brewing???

Thanks again

wook

biopharm

01/24/14 1:06 PM

#157940 RE: entdoc #157918

thanks entdoc, looks like Cotara, as well as Bavi got delayed just a bit. Here is an oldie but goodie and we see Cotara I-131 suppose to emerge back in 2008/2009

Looking forward to our next gap up rise... next week.

http://www.biotechsystems.com/breakingmarketnews/new_promise_for_therapeutic_radiopharmaceuticals.asp